Why the study?
The relationship between average blood glucose levels and incident CHD in individuals without diabetes mellitus remained to be investigated.
Does genetically proxied higher average blood glucose increase incident coronary heart disease in individuals without diabetes mellitus?
Does genetically proxied higher average blood glucose increase incident coronary heart disease in individuals without diabetes mellitus?
In individuals without diabetes mellitus, genetically proxied higher average blood glucose levels are linearly associated with an increased risk of incident coronary heart disease.
Answers are grounded in this paper and cite their sources.
Genetically proxied higher HbA1c associates with CHD risk in non-diabetics; extends linear glycemic evidence but leaves causal inference and intervention effects open.
Aims/hypothesis Our aim was to investigate the relationship between average blood glucose levels and incident CHD in individuals without diabetes mellitus. Methods To investigate average blood glucose levels, we studied HbA 1c as predicted by 40 variants previously shown to be associated with both type 2 diabetes and HbA 1c . Linear and non-linear Mendelian randomisation analyses were performed to investigate associations with incident CHD risk in 324,830 European ancestry individuals from the UK Biobank without diabetes mellitus. Results Every one mmol/mol increase in genetically proxied HbA 1c was associated with an 11% higher CHD risk (HR 1.11, 95% CI 1.05, 1.18). The dose–response curve increased at all levels of HbA 1c , and there was no evidence favouring a non-linear relationship over a linear one. Conclusions/interpretations In individuals without diabetes mellitus, lowering average blood glucose levels may reduce CHD risk in a dose-dependent way.
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: